Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Trimethyl orthoformate | HCID 9005 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | 2-Methyl-2-(piperazin-1-yl)propanamide | HCID 21748841 | — |
| Reactant | (2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)acetaldehyde | HCID 59605819 | — |
| Solvent | 1,2-Dichloroethane | HCID 11 | — |
| Product | HCID 59605461 | HCID 59605461 | 42.6% |
Reaction Steps
To a solution of (2-chloro-9-methyl-6-morpholin-4-yl-9H-purin-8-yl)acetaldehyde (110 mg, 0.37 mmol) in DCE (10 mL) was added 2-piperazin-1-ylisobutyramide (90 mg, 0.53 mmol), trimethyl orthoformate (0.20 mL, 1.86 mmol) and acetic acid (0.02 mL, 0.37 mmol). The reaction mixture was stirred at room temperature for 3 h, sodium triacetoxyborohydride (118 mg, 0.56 mmol) was added and the resulting mixture stirred for a further 2 days. The reaction mixture was loaded onto an Isolute® SCX-2 cartridge, the cartridge was washed with MeOH then the desired product eluted with 2 M NH3 in MeOH. The resulting residue was purified by column chromatography (Si—PCC, 0-20% MeOH in EtOAc) to give the title compound as a pale yellow solid (71 mg, 42%). LCMS (Method H): RT=2.40 min, [M+H]+ 451.5
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08394796B2 |
|---|
| Source dataset | uspto-grants-2013_03 |
|---|
| ORD ID | ord-594f2e3b34ee404ebd7a205bbfee7ecb |
|---|
| Source note | uspto-grants-2013_03 |
|---|